Ortin Laboratories Ltd - 539287 - Related Party Disclosure For The Quarter And Year Ended 31.03.2021
Related Party Disclosure for the quarter and year ended 31.03.202129-07-2021
Ortin Laboratories Ltd - 539287 - Related Party Disclosure For The Quarter And Year Ended 31.03.2021
Related Party Disclosure for the quarter and year ended 31.03.2021Ortin Laboratories Ltd - 539287 - Shareholding for the Period Ended June 30, 2021
Ortin Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click hereOrtin Laboratories Ltd - 539287 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- S Murali Krishna MurthyDesignation :- Managing Director / Whole Time DirectorOrtin Laboratories Ltd - 539287 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate u/r 74(5) of SEBI (DP) Regulations, 2018Ortin Laboratories Ltd - 539287 - Audited Results For The Quarter And Year Ended 31.03.2021
Audited results for the quarter and year ended 31.03.2021Ortin Laboratories Ltd - 539287 - Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31.03.2021
Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2021 ,inter alia, to consider and approve audited financial results for the quarter and year ended 31.03.2021Ortin Laboratories Ltd - 539287 - Announcement under Regulation 30 (LODR)-Meeting Updates
Board Meeting AdjournmentOrtin Laboratories Ltd - 539287 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance report for the Financial year 2020-21